Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
08/16/2007 | WO2007090854A1 Azetidine amino pyrimidine compounds for the treatment of inflammatory disorders |
08/16/2007 | WO2007090853A1 Enantiomers of amino pyrimidine compounds for the treatment of inflammatory disorders |
08/16/2007 | WO2007090852A1 Amino pyrimidine compounds for the treatment of inflammatory disorders |
08/16/2007 | WO2007090826A1 Piperidine derivatives as cxcr3 receptor antagonists |
08/16/2007 | WO2007090793A1 Nitrooxy-comprising derivatives of apraclonidine and brimodnidine as al pha2 -adrenergic receptor agonists |
08/16/2007 | WO2007090733A1 Nitrooxy derivatives suitable as alpha2 adrenergic receptor agonists |
08/16/2007 | WO2007090661A2 Active substance combination comprising azolylcarbinol compounds |
08/16/2007 | WO2007071442A3 Inhibitors of ccr9 activity |
08/16/2007 | WO2004007437A9 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
08/16/2007 | WO2003080856A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
08/16/2007 | WO2003031404A3 Processes for the preparation of substituted isoxazoles and 2-isoxazolines |
08/16/2007 | US20070191592 amidated peptide; stress-related conditions |
08/16/2007 | US20070191478 Methods of treating cardio pulmonary diseases with NO group compounds |
08/16/2007 | US20070191468 Amino alcohol compound |
08/16/2007 | US20070191412 Synergistic analgesic combination of opioid analgesic and cyclooxygenase-2 inhibitor |
08/16/2007 | US20070191401 Transplant rejection, autoimmune disease, autoimmune disease |
08/16/2007 | US20070191392 Dipeptide nitrile cathespin k inhibitors |
08/16/2007 | US20070191388 1-Benzyl-4-[4-(thiophene-2-carbonyl) piperazin-1-yl]-2-oxo-1,2-dihydro-3-cyano[1,8]-naphthyridine; antinflammatory, antiarthritic, anticarcinogenic, antitumor, antidiabetic; septic shock; acute respiratory distress syndrome; casrdiovascular disorders; angiogenesis inhibitors; autoimmune diseases; asthma |
08/16/2007 | US20070191310 Antiinflammatory agents; antiischemic agents; antiarthritic agents; antihistamines; multiple sclerosis; Alzheimer's disease; Huntington's disease; parkinson's disease; antiepileptic agents; 1-Stearoyl-2-{3-[2-(2,6-dichloroanilino)phenylacetamido]propanoyl}-sn-glycero-3-phosphocholine |
08/16/2007 | US20070191280 High Purity Lipopeptides |
08/16/2007 | US20070190612 31 Human Secreted Proteins |
08/16/2007 | US20070190132 Pharmaceutical compositions for oral and topical administration |
08/16/2007 | US20070190106 Phosphorus-containing compounds & uses thereof |
08/16/2007 | US20070190076 A bacterial preparation consisting of freeze dried, non-denatured Mycobacterium bovis and water, in an amount effective to stimulate leukocytic regulatory cells, used for the prevention and/or the treatment of cancer, autoimmune diseases, allergies and tuberculosis; vaccines |
08/16/2007 | US20070190054 Prevention and treatment of complement-associated disorders |
08/16/2007 | US20070190049 Use of A33 antigens and JAM-IT |
08/16/2007 | CA2641718A1 Bicyclic sphingosine 1-phosphate analogs |
08/16/2007 | CA2641685A1 3-heteroaryl-3,9-diazabicyclo[3.3.1]nonane derivatives as nicotinic acetylcholine receptor agonists |
08/16/2007 | CA2641501A1 Nitrooxy-comprising derivatives of apraclonidine and brimodnidine as al pha2 -adrenergic receptor agonists |
08/16/2007 | CA2641169A1 Antigenic gm-csf peptides and antibodies to gm-csf |
08/16/2007 | CA2638849A1 Antibodies that bind par-2 |
08/16/2007 | CA2635138A1 Piperidine derivatives as cxcr3 receptor antagonists |
08/16/2007 | CA2635137A1 Piperidine derivatives as cxcr3 receptor antagonists |
08/16/2007 | CA2627900A1 Compounds and compositions as lxr modulators |
08/15/2007 | EP1818343A2 Antibodies against human IL-12 |
08/15/2007 | EP1818342A2 Purified primate CTLA-8 antigens and related reagents |
08/15/2007 | EP1818333A1 Vanilloid receptor ligands and their use in treatments |
08/15/2007 | EP1818045A1 Antiphlogistic and analgesic compound for topical use in an area of an animal locomotive system |
08/15/2007 | EP1817294A1 1,2,3,4-tetrahydropyrazin-2-yl acetamides and their use as bradykinin antagonists for the treatment of inflammation related disorders |
08/15/2007 | EP1817279A2 17,20(z)-dehydro vitamin d analogs and their uses |
08/15/2007 | EP1817278A2 2-methylene-18,19-dinor-1alfa-hydroxy-homopregnacalciferol and its uses |
08/15/2007 | EP1817079A1 Treatment of inflammation |
08/15/2007 | EP1817021A1 Nsaid compositions exhibiting clinical superiority |
08/15/2007 | EP1817018A2 Hydrophobic polyamine amides as potent lipopolysaccharide sequestrants |
08/15/2007 | EP1673092B1 Heterocycle-substituted pteridine derivatives and their use in therapy |
08/15/2007 | EP1663244B1 Pteridine derivatives for the treatment of tnf-alpha-related diseases. |
08/15/2007 | EP1569896B1 Tetrahydro-naphthalene derivatives |
08/15/2007 | EP1496904B1 Use of pharmaceuticals containing n, n'-disubstituted piperazine compounds |
08/15/2007 | EP1496059B1 Fused bicyclic pyrimidine derivatives |
08/15/2007 | EP1451196B1 The use of substituted tetracyclic imidazole derivatives as anti-histaminics |
08/15/2007 | EP1385825B1 Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives |
08/15/2007 | EP1377590B1 Thiazolopyrimidine derivatives and use thereof as antagonists of the cx3cr1 receptor |
08/15/2007 | EP1355588B1 Device for delivery of therepeutic agents |
08/15/2007 | EP1343488B1 Treatment of statin side effects |
08/15/2007 | EP1339458B1 Combination comprising an agent decreasing vegf activity and an agent decreasing egf activity |
08/15/2007 | EP1322596B1 Zwitterionic tachykinin receptor antagonists |
08/15/2007 | EP1250137B1 Jak/stat pathway inhibitors and the use thereof for the treatment of primary generalized osteoarthritis |
08/15/2007 | EP1238070B1 Therapeutically useful synthetic oligonucleotides |
08/15/2007 | EP1198254B1 Carrier-drug conjugate |
08/15/2007 | CN1332018C Freezing dried mycobatctericsis preparation and its preparing method and use |
08/15/2007 | CN1331848C Tricyclic steroid hormone nuclear receptor modulators |
08/15/2007 | CN1331526C Method for producing turmeric stable prepn. |
08/15/2007 | CN1331515C Medicine for relaxing tendon, activating collateral, easing pain and its preparation process |
08/15/2007 | CN1331488C Prunella spike extract and its use |
08/15/2007 | CN1331486C Use of azalea as medicine for cardiac diseases |
08/15/2007 | CN101018810A Anti-synoviolin antibody |
08/15/2007 | CN101018799A Composition and method for inhibiting platelet aggregation |
08/15/2007 | CN101018782A Hydantoin compound for the treatment of inflammatory disorders |
08/15/2007 | CN101018779A Triazole compounds and their use as metabotropic glutamate receptor antagonists |
08/15/2007 | CN101018771A Derivatives of pyrazoline, procedure for obtaining them and use thereof as therapeutic agents |
08/15/2007 | CN101018770A PGD2 receptor antagonists for the treatment of inflammatory diseases |
08/15/2007 | CN101018546A (halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators |
08/15/2007 | CN101016560A Method of measuring biologically active substance vitality, cardiomyopeptidin and use thereof |
08/15/2007 | CN101016294A Substituted indole-3-oxalamide derivative with multiple bioactivity |
08/15/2007 | CN101015699A Polyethylene glycol-phosphatidyl ethanolamine polymer or medicinal acid addition salt and application thereof in pharmacy |
08/15/2007 | CN101015697A A local drug-release system and a method of the manufacture thereof |
08/15/2007 | CN101015675A Massage washing lotion |
08/15/2007 | CN101015670A Preparation process of traditional Chinese medicine lotion for treating closed trauma |
08/15/2007 | CN101015660A Medicine for treating common cold |
08/15/2007 | CN101015650A Zhuifengtouguhuoluo pills(capsule) and its prepn process |
08/15/2007 | CN101015643A Chinese medicine composition for treating chronic pelvic inflammatory disease and preparing method thereof |
08/15/2007 | CN101015641A Moxibustion medicine for treating pain of lumbus, leg, neck and shoulder |
08/15/2007 | CN101015637A Medical ointment plaster for curing articulation pain and preparation method thereof |
08/15/2007 | CN101015575A Process for preparing bupleurum root dropping pills |
08/15/2007 | CN101015572A Extraction method of korean pine cone extractive |
08/15/2007 | CN101015555A Inclusion compound of lornoxicam and hydroxypropyl-beta-cyclodextrin and its preparation method |
08/15/2007 | CN101015552A Ligustilide extract and its preparing process and application |
08/15/2007 | CN101015550A Preparing method of triptolide molecule microcapsule |
08/15/2007 | CN101015549A Preparing and detecting method of triptolide liposome nano granule |
08/15/2007 | CN101015543A Use of cinnamic acid and allyl benzoate compound with oxidation resistance function for protecting liver and brain damage |
08/15/2007 | CN101015542A Compound paracetamol injection for livestock and process for preparing same |
08/15/2007 | CN101015541A Diacetyl rhein dropping pills and its preparing process |
08/15/2007 | CN101015380A Producing method of health care beverage |
08/15/2007 | CN101015344A Method for preparing health care green onion |
08/15/2007 | CN101015313A Lotus-leaf lotus-plumule herb tea |
08/15/2007 | CN101015310A Lotus-leaf lotus-plumule tea |
08/14/2007 | US7257419 Method for attempting to establish a connection between a mobile station and a wireless communication system including a parameter identifying reason for a previously failed reconnection attempt and a parameter indicating a number of times that the reason occurred |
08/14/2007 | US7256267 Polynucleotide encoding a novel human serpin secreted from lymphoid cells, LSI-01 |
08/14/2007 | US7256216 Powder mixture of aminobutyric acid and solid polyol; therapy for brain disorders; central nervous system disorders; analgesics; headaches |
08/14/2007 | US7256211 Containing a carboxy-substituted thiazolylthio group, e.g., 15 alpha ,13E)-9-oxo-15-hydroxy-16-(4-fluoro-3-phenylphenyl)-5-(4-carboxythiazol-2-yl)-1,2,3,4,17,18,19,20-octanol-5-thia-8-azaprost-13-ene; EP4 agonistic action and are useful for treating diseases including immunological disorders and asthma |